Artesunate–dapsone–proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response

This publication has 28 references indexed in Scilit:

• Mutations indhfrinPlasmodium falciparumInfections Selected by Chlorproguanil‐Dapsone Treatment
  The Journal of Infectious Diseases, 2002
• The mode of action and the mechanism of resistance to antimalarial drugs
  Published by Elsevier ,2002
• The evolution of drug–resistant malaria: the role of drug elimination half–life
  Philosophical Transactions Of The Royal Society B-Biological Sciences, 2002
• Molecular Markers for Failure of Sulfadoxine‐Pyrimethamine and Chlorproguanil‐Dapsone Treatment ofPlasmodium falciparumMalaria
  The Journal of Infectious Diseases, 2002
• Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study
  Tropical Medicine & International Health, 2000
• Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand.
  The American Journal of Tropical Medicine and Hygiene, 1999
• Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub‐Saharan Africa
  Tropical Medicine & International Health, 1998
• Plasmodium falciparum:Detection of Polymorphisms in theDihydrofolate ReductaseandDihydropteroate SynthetaseGenes by PCR and Restriction Digestion
  Experimental Parasitology, 1998
• In Vivo Selection for a Specific Genotype of Dihydropteroate Synthetase ofPlasmodium falciparumby Pyrimethamine‐Sulfadoxine but Not Chlorproguanil‐Dapsone Treatment
  The Journal of Infectious Diseases, 1998
• Plasmodium falciparum:Kinetic Interactions of WR99210 with Pyrimethamine-Sensitive and Pyrimethamine-Resistant Dihydrofolate Reductase
  Experimental Parasitology, 1997